Skip to Main Content

WASHINGTON — They are little-known lawyers and professionals — with almost no experience in health care. And yet they are poised to play an outsized role in the federal effort to bring down high prescription drug prices.

The five men and women are in line to take charge of the Federal Trade Commission — a role that will let them decide whether to investigate companies over potentially anti-competitive tactics, whether to block mergers or acquisitions, and whether to demand more information about secretive business practices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!